Authors: ALBERT JM IOANNIDIS JPA REICHELDERFER P CONWAY B COOMBS RW CRANE L DEMASI R DIXON DO FLANDRE P HUGHES MD KALISH LA LARNTZ K LIN DY MARSCHNER IC MUNOZ A MURRAY J NEATON J PETTINELLI C RIDA W TAYLOR JMG WELLES SL

Citation: Jm. Albert et al., STATISTICAL ISSUES FOR HIV SURROGATE END-POINTS - POINT COUNTERPOINT/, Statistics in medicine, 17(21), 1998, pp. 2435-2462

Authors: RIDA W FAST P HOFF R FLEMING T

Citation: W. Rida et al., INTERMEDIATE-SIZE TRIALS FOR THE EVALUATION OF HIV VACCINE CANDIDATES- A WORKSHOP SUMMARY, Journal of acquired immune deficiency syndromes and human retrovirology, 16(3), 1997, pp. 195-203

Authors: RIDA W FLEMING T STEVENS C

Citation: W. Rida et al., ALTERNATIVE TRIAL DESIGNS - CONFERENCE SUMMARY, AIDS research and human retroviruses, 11(10), 1995, pp. 1317-1319

Authors: RIDA W FAST P HOFF R BARKER L

Citation: W. Rida et al., AIDS - MODELING EPIDEMIC CONTROL, Science, 267(5202), 1995, pp. 1251-1252

Authors: RIDA W MEIER P STEVENS C

Citation: W. Rida et al., DESIGN AND IMPLEMENTATION OF HIV VACCINE EFFICACY TRIALS - A WORKING GROUP SUMMARY, AIDS research and human retroviruses, 9, 1993, pp. 190000059-190000063